`
`US 7,772,209 K1
`(10) Number:
`United States Patent
`
`
`Niyikiza Sep. 26, 2019 (45) Certificate Issued:
`
`(54) ANTIFOLATE COMBINATION THERAPIES
`
`(75)
`
`Inventor: Clet Niyikiza
`
`(73) Assignee: Eli Lilly and Company
`
`Trial Numbers:
`
`IPR2016-00237 filed NOV. 24, 2015
`IPR2016-01335 filed Jun. 30, 2016
`IPR2016-Oll90 filed Jul. 1, 2016
`IPR2016-Ol34l filed Jul. 1, 2016
`IPR2016-00240 filed NOV. 24, 2015
`IPR2016-01337 filed Jun. 30, 2016
`IPR2016-Oll9l filed Jul. 1, 2016
`IPR2016-01343 filed Jul. 1, 2016
`IPR2016-00318 filed Dec. 14, 2015
`IPR2016-01340 filed Jul. 1, 2016
`IPR2016-01393 filed Jul. 8, 2019
`IPR2016-01429 filed Jul. 14, 2016
`
`Inter Partes Review Certificate for:
`
`Patent No.:
`Issued:
`Appl. No.:
`Filed:
`
`7,772,209
`Aug. 10, 2010
`11/776,329
`Jul. 11, 2007
`
`The results of IPR2016-00237 joined with IPR2016-
`01335,
`and
`IPR2016-01190
`and
`IPR2016-01341;
`IPR2016-00240
`joined with
`IPR2016-01337,
`and
`IPR2016-01191 and IPR2016-01343;
`IPR2016-00318
`joined with IPR2016-01340,
`IPR2016-01393,
`and
`IPR2016-01429 are reflected in this inter partes review
`certificate under 35 U.S.C. 318(b).
`
`
`
`INTER PARTES REVIEW CERTIFICATE
`
`U.S. Patent 7,772,209 K1
`Trial No. IPR2016-00237
`
`Certificate Issued Sep. 26, 2019
`
`1
`
`AS A RESULT OF THE INTER PARTES
`REVIEW PROCEEDING, IT HAS BEEN
`DETERMINED THAT:
`
`Claims 1-22 are found patentable.
`*
`>X<
`*
`>X<
`*
`
`